BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36497401)

  • 1. Secondary Malignancies after Ewing Sarcoma-Epidemiological and Clinical Analysis of an International Trial Registry.
    Kaiser I; Kauertz K; Zöllner SK; Hartmann W; Langer T; Jürgens H; Ranft A; Dirksen U
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ewing Sarcoma as Secondary Malignant Neoplasm-Epidemiological and Clinical Analysis of an International Trial Registry.
    Zöllner SK; Kauertz KL; Kaiser I; Kerkhoff M; Schaefer C; Tassius M; Jabar S; Jürgens H; Ladenstein R; Kühne T; Haveman LM; Paulussen M; Ranft A; Dirksen U
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults.
    Kube SJ; Blattmann C; Bielack SS; Kager L; Kaatsch P; Kühne T; Sorg B; Kevric M; Jabar S; Hallmen E; Sparber-Sauer M; Klingebiel T; Koscielniak E; Dirksen U; Hecker-Nolting S; Gerß JWO
    Cancer; 2022 May; 128(9):1787-1800. PubMed ID: 35195899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina.
    Villanueva G; Sampor C; Moreno F; Alderete D; Moresco A; Pinto N; Szijan I; Schaiquevich P; Felice MS; Rose A; Zubizarreta P; Sgroi M; Fandiño A; Chantada G
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29710. PubMed ID: 35451226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.
    Goldsby R; Burke C; Nagarajan R; Zhou T; Chen Z; Marina N; Friedman D; Neglia J; Chuba P; Bhatia S
    Cancer; 2008 Nov; 113(9):2597-604. PubMed ID: 18823030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.
    Groot HJ; Lubberts S; de Wit R; Witjes JA; Kerst JM; de Jong IJ; Groenewegen G; van den Eertwegh AJM; Poortmans PM; Klümpen HJ; van den Berg HA; Smilde TJ; Vanneste BGL; Aarts MJ; Incrocci L; van den Bergh ACM; Jóźwiak K; van den Belt-Dusebout AW; Horenblas S; Gietema JA; van Leeuwen FE; Schaapveld M
    J Clin Oncol; 2018 Aug; 36(24):2504-2513. PubMed ID: 29989856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Subsequent Malignant Neoplasms Following Hematopoietic Stem Cell Transplantation with Total Body Irradiation or Total Marrow Irradiation: Insights from Early Follow-Up.
    Ladbury C; Armenian S; Bosworth A; He T; Wong FL; Dandapani S; Han C; Liu A; Al Malki M; Rosenthal J; Stein A; Wong J
    Transplant Cell Ther; 2022 Dec; 28(12):860.e1-860.e6. PubMed ID: 36167306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006).
    Longhi A; Ferrari S; Tamburini A; Luksch R; Fagioli F; Bacci G; Ferrari C
    Cancer; 2012 Oct; 118(20):5050-9. PubMed ID: 22415578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
    J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study.
    Neglia JP; Friedman DL; Yasui Y; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL
    J Natl Cancer Inst; 2001 Apr; 93(8):618-29. PubMed ID: 11309438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
    Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
    J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort.
    Teepen JC; Kremer LC; van der Heiden-van der Loo M; Tissing WJ; van der Pal HJ; van den Heuvel-Eibrink MM; Loonen JJ; Louwerens M; Versluys B; van Dulmen-den Broeder E; Visser O; Maduro JH; van Leeuwen FE; Ronckers CM;
    Cancer Causes Control; 2019 Sep; 30(9):909-922. PubMed ID: 31300947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
    Dunst J; Ahrens S; Paulussen M; Rübe C; Winkelmann W; Zoubek A; Harms D; Jürgens H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):379-84. PubMed ID: 9788419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and outcomes in patients with secondary Ewing sarcoma.
    Applebaum MA; Goldsby R; Neuhaus J; DuBois SG
    Pediatr Blood Cancer; 2013 Apr; 60(4):611-5. PubMed ID: 22847990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.
    Arshi A; Sharim J; Park DY; Park HY; Yazdanshenas H; Bernthal NM; Shamie AN
    Spine J; 2017 May; 17(5):645-655. PubMed ID: 27856382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence and Prognosis of Secondary Lung Cancer in Patients with Primary Nasal Cavity and Sinus Squamous Cell Carcinoma.
    Feng J; Jin G; Song X
    Adv Ther; 2022 Jun; 39(6):2533-2543. PubMed ID: 35357667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tandem High-Dose Chemotherapy Increases the Risk of Secondary Malignant Neoplasm in Pediatric Solid Tumors.
    Lim H; Im M; Seo ES; Cho HW; Ju HY; Yoo KH; Cho SY; Kim JW; Lim DH; Sung KW; Lee JW
    Cancer Res Treat; 2024 Apr; 56(2):642-651. PubMed ID: 37997325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soft tissue sarcoma as a second malignant neoplasm in the pediatric age group.
    Bisogno G; Sotti G; Nowicki Y; Ferrari A; Garaventa A; Zanetti I; Favre C; Schiavetti A; Tamaro P; Carli M
    Cancer; 2004 Apr; 100(8):1758-65. PubMed ID: 15073867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary malignant neoplasms in testicular cancer survivors.
    Curreri SA; Fung C; Beard CJ
    Urol Oncol; 2015 Sep; 33(9):392-8. PubMed ID: 26072728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large Population Analysis of Secondary Cancers in Pediatric Leukemia Survivors.
    Yavvari S; Makena Y; Sukhavasi S; Makena MR
    Children (Basel); 2019 Nov; 6(12):. PubMed ID: 31795500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.